TransCon hGH

An investigational GHD treatment designed to improve patients' lives

An investigational GHD treatment designed to improve patients' lives

Vector-Smart-Object-copy

TransCon hGH is an investigational, long-acting human growth hormone prodrug administered weekly that releases somatropin as a potential therapy for children and adults with GHD.

Explore

You are about to access www.ascendispharma.us.
The information on this website is intended for residents of the United States. Click below to confirm you are a citizen and/or resident of the United States.

GO